StockData
Sionna Therapeutics, Inc. logo

Sionna Therapeutics, Inc. (SION) stock

SIONNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 10, 2026Score 7/30
$3.07−0.05 (-1.60%)

Close on Nov 17, 2026Market cap $138.80MP/E –Yield –

Sionna Therapeutics price to book ratio

The price-to-book ratio is market cap divided by shareholders' equity.

Sionna Therapeutics's price to book ratio was 0.6× on Nov 11, 2026, against 6.0× a year earlier.

Price to Book Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 20260.6×−5.1
2025Dec 31, 20255.7×–

More Sionna Therapeutics figures

See a number that looks wrong?